Skip Navigation

Press Releases

Asthma News Items

Filter Press Releases

May 12, 2016

Media Availability: Scientists Show Link Between Persistent Childhood Asthma and COPD

WHAT: Scientists funded by the National Heart, Lung, and Blood Institute have shown a link between persistent childhood asthma and chronic obstructive pulmonary disease (COPD). Persistent asthma is characterized by recurrent breathing difficulties irrespective of medication use. COPD is a debilitating lung disease that typically affects current or former smokers in their 40s or older.

May 3, 2016

NIH statement on World Asthma Day 2016

On World Asthma Day 2016, the National Institutes of Health reaffirms its commitment to support research to improve the lives of all people with asthma. NIH-funded research has advanced our understanding of asthma as a disease as well as the impact asthma has on the lives of those affected.  We have made great strides in learning how to treat and prevent asthma, and we are committed to ensuring that scientific discoveries move quickly into clinical practice to provide the best possible care for all people with asthma.

January 26, 2016

Asthma prevention study suggests vitamin D supplementation in pregnant women might affect specific immune responses in offspring

WHAT: Providing extra vitamin D to women during pregnancy raised their vitamin D levels without changing recurrent wheezing rates in their offspring by age 3 years, National Institutes of Health-supported research found. However, in these children, who are at high risk for developing asthma, blood tests showed lower levels of specific antibodies related to allergy development, if their mothers took extra vitamin D, according to results appearing in the Journal of the American Medical Association.

May 5, 2015

NIH statement on World Asthma Day 2015

On World Asthma Day 2015, the National Institutes of Health stands with the international community to renew our commitment to advance our understanding of asthma and develop effective strategies to manage and prevent the disease. Within a broad asthma research portfolio, NIH-supported scientists are making progress in understanding how certain exposures—such as to microbes, allergy-triggering substances (allergens) and pollution—may contribute to the development or worsening of asthma, and are working on new approaches to address these factors.

May 18, 2014

Vitamin D supplementation does not reduce asthma treatment failure in people with low Vitamin D, but some benefits suggested.

Supplementing inhaled corticosteroids (ICS) with vitamin D does not reduce the rate of treatment failure in patients with asthma and vitamin D insufficiency, finds a new NIH-funded study. The Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) trial randomized 408 adults with low vitamin D and mild/moderate asthma to receive the ICS ciclesonide supplemented with either high-dose vitamin D3 or placebo.

May 13, 2014

Asthma Awareness Month 2014: NIH continues its commitment to asthma research

May is Asthma Awareness Month, and the National Institutes of Health emphasizes the scientific progress being made in asthma research, from basic science, such as how lung cells work, to clinical trials on current and future treatments for the disease. NIH-led research includes studies of environmental factors, how the body’s own defense system plays a role, and the microbiome — all the microbial organisms that live in and on the human body.

February 11, 2014

NIH study seeks to improve asthma therapy for African-Americans

Researchers will enroll around 500 African-American children and adults who have asthma in a multi-center clinical trial to assess how they react to therapies and to explore the role of genetics in determining the response to asthma treatment. This new clinical study, which will take place at 30 sites in 14 states, is aimed at understanding the best approach to asthma management in African-Americans.

A photo of a doctor listening to a child's heart
May 8, 2013

NIH statement on Asthma Month 2013

For Asthma Awareness Month 2013, the National Institutes of Health stands with the international community to renew our dedication to improving the quality of life for the estimated 300 million people living with asthma worldwide. To most effectively manage asthma, we need to address the disproportionate impact of the disease on minorities and families at or below the poverty line. NIH is committed to reducing asthma disparities and improving asthma control for all who live with the disease.

September 13, 2012

No significant difference in asthma control across three approaches to adjust medication dose in mild asthma

A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person’s asthma worsened. The methods examined in this study were a patient-guided modification based on symptoms, an assessment made by an examining physician, or the results of a breath test to measure inflammation.

September 3, 2012

Inhaled corticosteroids for childhood asthma may affect adult height

Adults who had been treated previously with the inhaled corticosteroid budesonide as part of a children’s clinical study were, on average, about half an inch shorter than their study counterparts who were not treated with inhaled corticosteroids, according to research funded by the NIH. The half inch difference had been observed when the study participants were children, showing that, while the effect on height does not go away, it also does not get worse, the researchers say.

Page 1 of 6

Pages